However, DKK2 methylation was not statistically associated with age, tumor size, clinical stage, metastasis, or ER, PR, HER2 status of breast carcinoma patients through analyzing the DKK2 promoter methylation and patient clinicopathological characters. Here, ERBB2 is linked to breast carcinoma.